5-chloro-1H-1,2,4-triazole-3-carboxylic acid N,N-diethylethanamine salt, 95.0%, 5g

ethyl 6-oxo-6-[4-(3-pyrrolinomethyl)phenyl]hexanoate, 97.0%, 1g

(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl acetate, 95.0%, 5g

6-Bromo-5-methyl-2,3-dihydro-1H-inden-1-one, 95.0%, 1g

N-sec-Butylurea, 98%+, 500g

1-Bromo-2-naphthoic Acid>98.0%(GC)(T)1g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline>98.0%(GC)(T)1g

2-Amino-3-(3-bromo-4-hydroxyphenyl)propanoic acid, 95.0%, 5g

3-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine dihydrochloride, 95.0%, 250mg

ETHYL (1S,2S)-2-(HYDROXYMETHYL)CYCLOPROPANE-1-CARBOXYLATE, 95%, 250mg

(5-METHYL PYRIDIN-3-YL)METHAMINE HCL, 95.0%, 100mg

Laevulinic acid, min. 98%, for synthesis, 2.5 kg, glass packaging

2,2-Difluorocyclopropylamine hydrochloride, 97.0%, 500mg